EPHB4 and in situ carcinoma: 21 of the 24 (88%) CIS positive tumor specimens stained with strong EphB4 signal (P<0.001, Table S2 in File S1), while only 7 of the 10 (70%) CIS negative tumor specimens stained with strong signal strength (not significant, Table S2 in File S1).